Evidence map›Paper›PMID 38725253›Full record

ArticleWomen's health (London, England)

The role of clinical breast examination and fine needle aspiration cytology in early detection of breast cancer: A cross-sectional study nested in a cohort in a low-resource setting.

Alex Mremi, Angela Pallangyo, Thadeus Mshana, Onstard Mashauri, Walter Kimario, Gilbert Nkya, Theresia Edward Mwakyembe, Edson Mollel, Patrick Amsi, Blandina Theophil Mmbaga

Abstract read
In one paragraph

Article in Women's health (London, England). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Alex MremiDepartment of Pathology, Kilimanjaro Christian Medical Centre, Moshi, Tanzania.ORCID 0000-0001-7226-0168
Angela PallangyoDepartment of Pathology, Kilimanjaro Christian Medical Centre, Moshi, Tanzania.
Thadeus MshanaFaculty of Medicine, Kilimanjaro Christian Medical University College, Moshi, Tanzania.
Onstard MashauriFaculty of Medicine, Kilimanjaro Christian Medical University College, Moshi, Tanzania.
Walter KimarioFaculty of Medicine, Kilimanjaro Christian Medical University College, Moshi, Tanzania.
Gilbert NkyaDepartment of Pathology, Kilimanjaro Christian Medical Centre, Moshi, Tanzania.
Theresia Edward MwakyembeFaculty of Medicine, Kilimanjaro Christian Medical University College, Moshi, Tanzania.
Edson MollelNorthern Zone Blood Transfusion Center (NZBTC), Moshi, Tanzania.
Patrick AmsiDepartment of Pathology, Kilimanjaro Christian Medical Centre, Moshi, Tanzania.
Blandina Theophil MmbagaFaculty of Medicine, Kilimanjaro Christian Medical University College, Moshi, Tanzania.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBreast cancer is prevalent worldwide, with disparities in screening, diagnosis, treatment outcomes, and survival. In Africa, the majority of women are diagnosed at advanced stages, affecting treatment outcomes. Screening is one of the best strategies to reduce mortality rates caused by this cancer. Yet in a resource-constrained setting, there is limited access to screening and early detection services, which are available only at a few referral hospitals.

objectivesWe aimed to evaluate the prevalence and screening results of breast cancer using clinical breast examination coupled with fine needle aspiration cytology in a resource-constraint setting.

designA combined cross-sectional and cohort study.

methodsWomen at risk of developing breast cancer in the Kilimanjaro region of Tanzania were invited, through public announcements, to their primary healthcare facilities. A questionnaire was used to assess the participants' characteristics. The women received a clinical breast examination, and detectable lesions were subjected to a confirmatory fine needle aspiration cytology or an excisional biopsy. Preliminary data from this ongoing breast cancer control program were extracted and analyzed for this study.

resultsA total of 3577 women were screened for breast cancer; their mean age was 47 ± 7.53 years. About a third of them (1145, 32%) were practicing self-breast examination at least once a month. Of 200 (5.6%) with abnormal clinical breast examination, 18 (9%) were confirmed to be breast cancer, making the prevalence to be 0.5%. The vast majority of participants with breast cancer (13, 72.2%) had early disease stages, and infiltrating ductal carcinoma, no special type, was the most common (15, 83.3%) histopathology subtype. Hormonal receptor status determination results indicated that 11 (61.1%), 7 (38.9%), and 5 (27.8%) of the tumors overexpressed estrogen receptor, progesterone receptor, and human epidermal receptor-2, respectively.

conclusionOur study demonstrates 5.6% of Tanzanian women have abnormal clinical breast examination findings, with 9% having breast cancer. Nearly three-quarters (72.2%) of breast cancer screened for early disease were detected in the early disease stages. This finding suggests that organized screening with clinical breast examination coupled with fine needle aspiration cytology, which is a simple and cost-effective screening method, has the potential to improve early detection and outcomes for breast cancer patients in a resource-constraint setting.

Indexed as

Breast NeoplasmsEarly Detection of CancerAdultAgedBiopsy, Fine-NeedleCohort StudiesCross-Sectional StudiesFemaleHumansMass ScreeningMiddle AgedPhysical ExaminationPrevalenceTanzaniabreast cancerclinical breast examinationfine needle aspiration cytologyresource-constraint setting

Identifiers

PMID38725253
PMCPMC11084987

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.